Severe diarrhea was reported in 1% of patients receiving Trulance vs 0.1% of placebo-treated patients1
2.5% discontinuation rate for Trulance vs 0.4% for placebo1
1.2% discontinuation rate due to diarrhea vs 0% for placebo1
Reported in at least 2% of Trulance-treated patients with IBS-C and at an incidence greater than placebo1